MIT researchers have designed a machine that can rapidly produce large quantities of customized peptides. This technology could help researchers rapidly generate new peptide drugs to test on diseases including cancer, diabetes, and bacterial infections.
There's good news for kids with epilepsy. While several new drugs have come out in the last several years for adults with epilepsy, making those drugs available for children and teenagers has been delayed due to the challenges of testing new drugs on children. But an analysis of all the research published on adults and children shows that the positive results seen in adults appear to be similar in children.
Researchers from Kumamoto University, Japan have developed an insulin release system with sustained and controllable delivery. The system combines two original technologies, SPRA and PPRX, which provide complimentary benefits for insulin delivery.
Development of new strategies and novel drug design to treat trophoblastic diseases and to provide pregnancy success are of crucial importance in maintenance the female reproductive health.
Physicians should be well-versed in the herbal medications heart disease patients may take to be able to effectively discuss their clinical implications, potential benefits and side effects -- despite a lack of scientific evidence to support their use, according to a review paper published today in the Journal of the American College of Cardiology.
Triboelectric nanogenerators (TENG) convert mechanical energy harvested from the environment to electricity for powering small devices such as sensors or for recharging consumer electronics. Now, researchers have harnessed these devices to improve the charging of molecules in a way that dramatically boosts the sensitivity of a widely-used chemical analysis technique.
Publicly funding essential medicines could cover the cost of nearly half of all prescriptions in Canada, removing financial barriers for Canadians while saving $3 billion per year.
Universal public coverage of 117 essential medicines could address the needs of most Canadians for pharmaceutical drugs, and possibly save more than $4 billion a year, according to a new study published in CMAJ (Canadian Medical Association Journal).
Sometimes cells spit out things we don't want them to -- like medications. Researchers have determined the three-dimensional structure of a tiny pump that expels, among other things, chemotherapy agents. This new knowledge could lead to the design of more effective drugs.
A powerful class of antibiotics provides life-saving relief for people with cystic fibrosis; however, a new study for the first time reveals the levels at which high cumulative dosages over time significantly increases the risk of permanent hearing loss in these patients. The study suggests physicians who treat patients with cystic fibrosis may be able to consider alternative strategies for treating the symptoms of respiratory infections associated with CF.